You are here

RAC Vaccines and Vaccination Group

Primary tabs

RAC Workgroup Efforts Focused on Vaccines and Vaccination

The Resilient American Communities (RAC) Vaccines and Vaccination Group is examining and acting on the issues surrounding vaccines development, distribution, vaccination logistics and execution, as well as vaccination strategy, safety, efficacy, trust, and hesitancy.  Special attention is currently focused on COVID-19 vaccines and vaccination. 

Members

Hank Rappaport Jan Booher John Girard Kathleen H mdmcdonald mike kraft

Email address for group

rac-vaccination@m.resiliencesystem.org

Trusting a Covid-19 Vaccine: What’s Next? --On line discussion Friday, April 9, 1 PM ET

The CSIS Global Health Policy Center invites you to join us for an online event:
 

Trusting a Covid-19 Vaccine:
What’s Next? 

 

Friday, April 9, 2021

1:00 p.m. to 2:00 p.m. EDT

 

 Join the discussion here → 
 

 

A conversation with

Bruce Gellin

President of Global Immunization
Sabin Vaccine Institute
 

Margaret “Peggy” Hamburg

Former Commissioner, U.S. Food and Drug Administration
Interim Vice President of Global Biological Policy and Programs
Nuclear Threat Initiative
 

Juliette Kayyem

Senior Belfer Lecturer in International Security
Harvard Kennedy School of Government
 

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Moderna’s COVID-19 vaccine provides antibodies for at least 6 months after the second dose but fades for older persons

Antibodies persisted 6 months after the second dose of Moderna's COVID-19 vaccine in younger and middle-age adults, but were diminished in older adults when using more sensitive assays, according to data from an ongoing phase I trial.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks